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treat chronic musculoskeletal pain. Treatment in these cent-
ers is provided by a team of specialists in anesthesiology, 
psychiatry and orthopedics as well as the relevant para-
medical professionals. The therapeutic strategy is based 
on a cognitive-behavioral approach, and patients are taught 
about methods for restoring physical function and coping 
with pain, mostly with drugs and exercise therapy, so that 
any pain present does not impair function and the patient 
can reintegrate into society.
Introduction
A large majority of patients visiting hospitals for physi-
cal ailments are there because of bodily pain. Such com-
plaints commonly involve musculoskeletal pain, such as 
in the limbs, neck and lower back. Most such patients visit 
orthopedic clinics in Japan. The large number of individu-
als suffering from musculoskeletal pain means that ortho-
pedic clinics bear a large social responsibility. The thera-
peutic strategies used in orthopedic clinics begin with a 
diagnosis based on physical and radiological findings, but 
many issues exist at present. In particular, for patients who 
have suffered long-term chronic pain, an approach based 
on the conventional biochemical model often does not lead 
to relief of symptoms. The Japanese Ministry of Health, 
Labor and Welfare thus published a proposal in 2010 from 
a “Study Panel on Chronic Pain” that laid out a future 
approach for the medical treatment of pain (http://www.
mhlw.go.jp/stf/houdou/2r9852000000ro8f.html). We herein 
review epidemiological studies conducted in Japan, such as 
studies of the prevalence of musculoskeletal pain, as well 
as biopsychosocial issues in the diagnosis and treatment of 
musculoskeletal pain. We also discuss future prospects for 
the treatment of musculoskeletal pain.
Abstract According to a recent survey, about 15 % of the 
Japanese population suffers from moderate-severe chronic 
musculoskeletal pain persisting for at least 6 months. Social 
factors and related psychological factors (including depres-
sion) thus appear to greatly affect chronic musculoskeletal 
pain. This suggests the need for measures that take these 
factors into account. Treatment for musculoskeletal pain at 
present is generally based on a biomedical model that has 
been used for many years in this field, and modern medical 
imaging technologies have been a high priority to support 
this model and treatment strategy. Under the concept of the 
biomedical model, nonsteroidal antiinflammatory drugs, 
channel blockers and opioid analgesics are generally used 
as pharmacotherapy to alleviate chronic pain. However, 
these drugs are commonly associated with problems such 
as adverse effects, drug dependency and drug abuse, and 
they must be used with care. Surgery may also be effec-
tive in treating certain diseases, but studies have shown that 
many patients suffer residual chronic pain even after such 
treatment. Besides, exercise therapy has been found to be 
effective in treating many different types of chronic pain. 
Lately, various countries have been launching interdiscipli-
nary pain centers that use a multidisciplinary approach to 
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Epidemiology of musculoskeletal pain in Japan
While details such as the strength and disease duration 
associated with the type of pain examined vary with survey 
methods, the population with musculoskeletal pain also dif-
fers between studies. In the comprehensive survey of liv-
ing conditions conducted in Japan, low back pain, shoulder 
stiffness and joint pain always rank the highest in every age 
group for complaints by the public. Among males, low back 
pain is the most common complaint in all age groups start-
ing with those in their 30s, and the prevalence of such com-
plaints tends to increase with age. In comparison, shoulder 
stiffness is the most common complaint of females in their 
20s–50s, and low back pain is the most common complaint 
from their 70s on. At the same time, the number of com-
plaints of limb joint pain increases with age. Numbness is 
commonly seen in clinical settings of musculoskeletal ail-
ments and tends to increase with age for individuals, but 
numbness alone does not greatly interfere with daily rou-
tines, while the presence of pain does [1].
A survey of the underlying illnesses that bring patients 
to the hospital showed treatment for low back pain as the 
fourth greatest problem among males and the second great-
est among females (Fig. 1).
According to the 2010 comprehensive survey of living 
conditions, a survey of the factors leading to the need for 
assistance or nursing care determined that musculoskeletal 
disorders are the top ranking at 22.9 %, with falls or frac-
tures accounting for 10.2 % and joints disease for 10.9 %. 
These findings show that musculoskeletal pain is not only 
highly prevalent in the population, but also a significant 
healthcare economics concern for Japan as a country that is 
already in the midst of an economic crisis and a challenge 
that the national government must address. In response, the 
Ministry’s study panel on chronic pain formed a research 
group that has been conducting research to investigate the 
current state of chronic musculoskeletal pain and intracta-
ble pain. This research group has been undertaking detailed 
surveys on chronic musculoskeletal pain since 2010.
Nakamura et al. administered questionnaires to about 
10,000 people in Japan [2] and reported that 15.4 % of the 
population experienced musculoskeletal pain persisting for 
at least 6 months (Fig. 2a), that the prevalence of such pain 
is high among those in their 30s–50s (an age group com-
prising the key productive years; Fig. 2b), that the preva-
lence of chronic pain is higher in large urban areas than 
in rural districts (Fig. 3) and that the frequency of chronic 
pain affecting the lower back, shoulders, neck and knees is 
high. Other findings from that survey were that the preva-
lence of pain was higher among office workers and profes-
sionals than among those working in primary industries 
such as forestry or fishery cooperatives, that there were 
Fig. 1  Top five patient care 
diseases from a comprehensive 
survey of living conditions con-
ducted in Japan (2013/2010). 
Low back pain ranks fourth 
highest in males and second 
highest in females
Fig. 2  Prevalence of musculoskeletal chronic pain in Japan; 15.4 % 
of the population experienced musculoskeletal pain persisting for at 
least 6 months (a). The prevalence of such pain is high among those 
in their 30s–50s (an age group comprising the key productive years; 
b). (From Nakamura M. et al. J Orthop Sci 2011;16:424–32)
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similar numbers of individuals visiting hospitals and clinics 
as those visiting folk remedy (acupuncture, massage, etc.) 
medical services for musculoskeletal pain treatment (about 
20 % for each), that a large majority of individuals in pain 
were not receiving treatment at a clinic or hospital, and 
that about half of patients switched hospitals/clinics during 
treatment.
Concerning another aspect of chronic musculoskeletal 
pain, many cases are strongly related to degenerative dis-
eases that accompany aging such as osteoarthritis. Indeed, 
it has been pointed out that there is a larger population of 
older people in pain in mountain village areas than in urban 
areas [3].
Besides, psychosocial backgrounds are known to affect 
the development and maintenance of musculoskeletal pain 
chronicity. An epidemiological survey called the Hisay-
ama study examined the psychosocial background behind 
musculoskeletal pain and demonstrated that individuals 
with chronic low back pain often suffer depression and/
or anxiety, with a particularly high prevalence of chronic 
pain among those with a tendency to alexithymia (i.e., an 
inability to identify their emotions; Fig. 4) [4]. In a survey 
we conducted in Owariasahi City, we found a high preva-
lence of chronic pain among those living alone (Table 1) 
[5]. Interestingly, people living alone showed a high score 
on the Kessler Psychological Distress Scale (K6) and a low 
score on the EQ-5D, suggesting this factor may be influ-
ential in the development and maintenance of chronic pain 
conditions.
Overall, these results suggest that the social background 
(super-aged society, nuclear family, working environment, 
etc.) and its associated psychological factors may affect the 
development of chronic musculoskeletal pain in addition to 
bodily dysfunctions.
Problems in the diagnosis, goal setting 
and treatment of musculoskeletal pain
The musculoskeletal system consists of the peripheral 
organs (muscle, joint, bone, vascular system, etc.) and sen-
sory/motor/autonomic nervous systems (brain, spinal cord, 
peripheral nerve); complicated mechanisms underlie muscu-
loskeletal pain. Therefore, it is essential to check and analyze 
the patients from many perspectives before the determination 
of the diagnosis/goal setting and therapeutic intervention.
Generally, analysis needs to clarify whether a specific 
patient’s experience of pain carries a nociceptive component, 
neuropathic component or biomechanical problems (such as 
postural or alignment problems) and so forth. Psychosocial 
factors must also be considered in addition to the above if 
pain is not resolved and becomes prolonged (Fig. 5).
In addition, we have noted several concerns about mak-
ing the diagnosis and treatment.
Fig. 3  City size and chronic musculoskeletal pain in Japan. The 
prevalence of chronic pain is higher in large urban areas than in rural 
districts. (From Nakamura, M. et al. J Orthop Sci 2011; 16: 424–32)
Fig. 4  Self-reported pain prevalence according to the Toronto Alex-
ithymia Scale (TAS-20) score levels in a general population from 
the Hisayama Study health survey. Acute pain: <6 months of pain. 
Chronic pain: pain that experienced for 6 months or longer. (From 
Shibata M et al. Plos One 2014;9:e90984)
Table 1  Household size and chronic pain associate factors
NRS Numerical Rating Scale, K6 Kessler Psychological Distress 
Scale
Household size Pain (NRS) EQ-5D K6 Chronic pain (%)
1 5.5 0.79 4.6 27
2 (with spouse) 5.1 0.85 2.5 18.2
2 (with parent) 4.6 0.85 4.2 11.8
2 (other pattern) 5.6 0.84 2.4 8.7
3 5.1 0.87 3.5 15.6
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Problems
Biomedical model-based diagnosis
Diagnosing and specifying the pain source by simple bio-
medical examinations are generally not promising. For 
example, specific low back pain, which involves a certain 
pain source in the lumbar spine, may be caused by prob-
lems with the intervertebral discs, facet joints, nerve roots 
or muscles of the lower back. Diagnoses for pain in these 
areas are often based on radiological findings and physi-
cal examinations. However, statistics from the “Research 
on Osteoarthritis Against Disability” (ROAD) study deter-
mined that while X-rays confirm osteoarthritis in 30 million 
people, only about 10 million suffer pain, indicating a high 
rate of false-positive results from the perspective of using 
X-rays as a diagnostic tool for pain [6, 7]. Similarly, sta-
tistics on osteoarthritis as the most common cause of knee 
pain showed that only about one-third of patients identified 
radiographically as having the disease (about 8 million in 
Japan) actually suffer pain. An extremely large number of 
false-positive results is also seen with spinal MRI, in which 
evidence of epidural compression is present, but not associ-
ated with pain. Conversely, many patients experience pain 
but show unclear imaging findings.
The overseas literature on causes of chronic low back pain 
indicates that a cause can only be identified in about 15 % 
of cases even after various tests, and all other cases are clas-
sified as nonspecific low back pain [8]. In other words, the 
problem underlying low back pain is unlikely to be under-
stood and linked to an actual diagnosis unless a diagnosis is 
made based on a detailed knowledge of patient background 
information, including physical findings such as posture, his-
tory of the pain, and work-related and environmental factors. 
For these reasons, provocation tests and nerve blocks at pain 
sites are used for functional diagnosis [9]. Nevertheless, we 
have to mention that a strong placebo effect is known to be 
associated with these invasive trials/testings [10].
Typical psychosocial concerns that influence pain 
chronicity
When providing treatment, it is necessary to reaffirm that 
“pain” represents “an unpleasant sensory and emotional 
experience” registering in the brain.
Indeed, it is important to recognize that organic treat-
ment approaches often prove unsuccessful in patients with 
chronic musculoskeletal pain who suffer an element of dis-
torted perception of the pain in addition to those with cog-
nitive impairment. The following problems should also be 
considered as potential contributors to prolonged pain:
•	 Effect of stigmatization: provision of a diagnosis or 
words implying a diagnosis may affect symptoms (for 
example, a diagnosis of a herniated disc based on imag-
ing evidence may lead a patient to consider the hernia as 
the root of all of their symptoms);
•	 Incentivization of the illness (for example, worker’s 
compensation or accident insurance benefits or if a 
pathology exists in the family); or
•	 An environment that causes patients to focus exces-
sively on their pain or in which they have no other 
option but to do so.
Goal settings
Musculoskeletal pain commonly becomes chronic. How-
ever, it is often the case that not only functional, but also 
Fig. 5  Important diagnostic 
check points to analyze chronic 
pain conditions. To make a 
therapeutic program for chronic 
pain patients, it is necessary to 
check both the characteristics of 
pain and pain simultaneously
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numerous components, such as psychosocial issues, cause 
the pain to become prolonged. Before providing treatment, 
detailed examination of the clinical condition at the site of 
the pain is certainly essential, but analysis of the condition 
should also include observation of the patient from various 
perspectives, including their environment.
After assessing many aspects, the therapeutic goal 
should be considered not only from the perspective of pain 
intensity control, but also from the perspective of improv-
ing the ADL and QOL as a matter of primary importance.
General indications, usage and concerns of individual 
therapeutic approaches
Pharmacotherapy
Since many causes of musculoskeletal pain involve an 
inflammatory component, nonsteroidal antiinflammatory 
drugs (NSAIDs) are currently generally prescribed as first-
line pharmacotherapies. However, recent research suggests 
that pharmacotherapies should take neural mechanisms into 
account, even in cases of acute trauma. Indeed, the pain 
signal transmitted to the spinal cord through primary affer-
ents causes a dorsal root reflex that promotes the release 
of inflammatory neuropeptides from the peripheral nerves 
and triggers neurogenic tissue inflammation. Moreover, 
as many types of painful ailments such as low back pain 
become chronic, pain that is initially nociceptive may cause 
defensive muscle contractions or neuropathic pain. Accord-
ingly, when prescribing drugs, it is necessary to consider 
inflammation and nociceptive pain, muscular components 
and nervous system components (including neuropathic 
pain) at the same time.
As analgesic medications (such as anxiolytics, antide-
pressants and anticonvulsants) have recently come into 
common use for treating pain (particularly neuropathic 
pain) in the field of orthopedics, we must consider the 
adverse effect of these medications since many orthope-
dic providers are not familiar with these drugs. In Japan, 
benzodiazepines are frequently used as anxiolytics over the 
long term, but the Food and Drug Administration (FDA) in 
the USA does not recommend these agents for long-term 
use because of the development of resistance to the effects, 
the risk of drug dependency and the occurrence of with-
drawal symptoms when taking the patient off these drugs. 
Anticonvulsants suppress the transmission of pain signals 
by blocking neural excitation and neurotransmitter release. 
However, they may also trigger numerous side effects, 
such as drowsiness and dizziness, because of their actions 
in ion channels (sodium channels, calcium channels, etc.) 
distributed throughout the nervous system. It is particu-
larly important to note that elderly patients or patients with 
spinal cord disorders who may have reduced functioning 
in the nervous system may be at a higher risk of falls than 
usual and should take extra care when using these drugs. 
Opioids have also come into use for treating musculoskel-
etal pain. In addition to the unique side effects of opioids 
such as nausea, opioids have been noted for associations 
with drug resistance and dependency as well as social prob-
lems such as drug abuse in other countries. Medical pro-
viders must become well versed in the use of these drugs 
and only prescribe them to patients who are indicated while 
closely monitoring the dosage. While the appropriate use 
of pharmacotherapies can benefit patients, drug effects are 
often limited and the number needed to treat (NNT; the 
number of patients who must be treated for 1 patient to 
achieve high efficacy against their pain, i.e., reducing pain 
by half) in the treatment of neuropathic pain ranges from 
about 3 to 10 (Fig. 6) [11].
According to reports on evidence-based medicine to 
date, NSAIDs, intra-articular injection of hyaluronic acid 
and exercise therapy have been effective for osteoarthritis-
associated joint pain, and the Osteoarthritis Society Inter-
national has created guidelines [12]. A Japanese version 
has also been developed. However, many people do not 
see sufficient improvement with these conservative treat-
ments and choose artificial joint replacement as an opera-
tive treatment.
Overall, it is therefore important to remember that 
few patients achieve complete relief from pain using 
Fig. 6  The number needed to treat (NNT) with analgesic drugs for 
neuropathic pain. Numbers needed to treat (NNT) values for various 
drug classes in all central and peripheral neuropathic pain conditions. 
BTX-A botulinum toxin type A; TCAs tricyclic antidepressants; SNRIs 
serotonin noradrenaline reuptake inhibitors; SSRIs selective serotonin 
reuptake inhibitor. The figure illustrates the change from 2005 values 
in light gray to 2010 values in dark gray. The circle sizes indicate the 
relative number of patients who received active treatment drugs in tri-
als for which dichotomous data were available. [From Finnerup et al. 
Pain 150(3) pp 573–581]
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pharmacotherapy alone. The musculoskeletal system com-
prises organs that maintain their performance through move-
ment, and care should be taken to avoid overprescribing drugs.
Physiotherapy
Manual physiotherapy, thermotherapy and traction therapy 
have been used for many years, and while these options 
do offer temporary relief from muscle pain, few patients 
achieve complete remission. Meta-analysis of exercise ther-
apy has been reported to reduce pain and improve function-
ing in those with chronic pain (lasting at least 12 weeks) 
and to be equally effective to no treatment or conservative 
treatment in those with acute pain (lasting up to 6 weeks) 
[13]. A summary of systematic reviews from countries 
outside Japan showed exercise therapy to be effective for 
treating a wide range of ailments, including chronic low 
back pain [14]. When applying a physiotherapy or exercise 
therapy approach, methods in which the patient only pas-
sively receives treatment may have only temporary effects. 
Instructing patients on how to perform the treatment them-
selves may be necessary, even if doing so does not offer 
complete relief from pain.
Surgical treatment
Surgical/operative treatment has the potential to signifi-
cantly alleviate symptoms, for example by decompression 
of the affected nerves or with artificial joints and other 
types of reconstructive surgery in the musculoskeletal sys-
tems. It is important, however, to remember that operative 
techniques in invasive treatment have their own limitations, 
and this approach is not infallible.
Surgery on the lumbar spine is performed to relieve 
compression of nerve roots or the cauda equina caused by 
a narrow canal or herniated disc to alleviate neuralgia. Dur-
ing surgery, multifidus muscle retraction and separation of 
perineural tissues in the spinal canal need to be performed, 
but the former may result in denervation of the multifidus 
muscle, and the latter may result in perineural adhesions 
(e.g., epidural adhesions), among other serious conse-
quences [15]. Postoperatively, patients may experience loss 
of muscle strength in the back or fatigability, which may 
be accompanied by varying degrees of low back pain or 
adhesive pain and numbness. Indeed, in one randomized 
controlled trial (RCT), operative treatment showed better 
outcomes on clinical presentation than conservative treat-
ment in the long term, but the difference between the two 
decreased after 10 years [16]. In another RCT on patients 
with pain lasting several weeks, no long-term differences 
in outcome were seen between patients who continued con-
servative treatment and those who underwent early surgery 
[17, 18]. These findings have been incorporated into the 
guidelines of the Japanese Orthopedic Associations. How-
ever, attention must be paid to new treatments for lumbar 
disc diseases, such as condoliase treatment, which are con-
tinuing to be developed.
Appropriate indications for surgery for low back pain in 
Japan are generally fractures (compression fracture, spon-
dylolysis, etc.) and pathologies resulting from nerve com-
pression. Concerning about spondylolysis, the incidence of 
lumbar spondylolysis in the Japanese general population 
was 5.9 % [19]. However, it should be noted that many of 
them are asymptomatic.
Pain from such problems as nonunion of a spinal com-
pression fracture has recently been treated with vertebro-
plasty [20, 21] or kyphoplasty [22] as surgical approaches 
to treat individuals with chronic back pain. However, these 
procedures are generally for older adults with bone loss. 
Moreover, these interventions carry their own risks and 
may lead to new problems after surgery, such as new frac-
tures. From the perspective of preventive care, new treat-
ment methods are needed.
Concerning joint surgery, the number of artificial joint 
procedures in Japan is growing dramatically since many 
people do not see sufficient improvement with these con-
servative treatments. Including those with osteoarthritis 
of the hip or knee, as many as 100,000 people a year are 
choosing joint replacement surgery. Artificial joints are cur-
rently used as a final resort, but generally cannot achieve 
the range of movement required for activities of the Jap-
anese lifestyle, such as kneeling. Moreover, a study from 
outside Japan showed that 8–23 % of patients still experi-
ence residual pain after receiving an artificial joint [23], 
indicating that many challenges remain.
Cognitive behavioral therapy and multidisciplinary 
approaches
Generally, a biomedical approach is utilized to clarify the 
cause of musculoskeletal pain and to use drugs and/or sur-
gery to remove or alleviate the problem. However, pain is 
not an entirely biological issue and has many components, 
including social and psychological aspects. These compo-
nents are almost always tightly interwoven in patients with 
refractory pain. Remembering the role these factors may 
play when treating patients with musculoskeletal pain is 
therefore important. For patients who are strongly engulfed 
in their pain psychologically, treatment should not focus 
solely on removing the pain, but instead should also treat 
their psychological and social difficulties with the aim of 
improving activities of daily living (ADL) and quality of 
life (QOL). This approach is based on the biopsychosocial 
model, which stresses the consideration of psychologi-
cal factors and social factors as equally important to bio-
logical factors in patients with pain. This approach employs 
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cognitive-behavioral therapy, which is based on operant 
conditioning to reduce painful behaviors and enable the 
patient to coexist with the pain [24].
Specifically, this approach involves changing the 
patient’s thinking and behavior patterns from “I cannot do 
XXX because I feel pain” to “I can do XXX despite the 
pain.” This can both improve the ADL and QOL and create 
conditions under which the patients are not overwhelmed 
by their experience of pain (Fig. 7).
In addition to specialists in orthopedics, anesthesiol-
ogy and other fields who treat functional disorders, it is 
important to use a multidisciplinary approach, including 
psychiatrists, clinical psychologists and others specializing 
in psychiatry/psychology to set patients along a more posi-
tive path (Fig. 8). The role of the co-medical team together 
with the doctor is important. For example, a nurse, with a 
point of view that is different from the doctor, carries out 
the psychological support of patients and their families. In 
Fig. 7  Pain virtuous cycle. 
Patients can leave the non-
virtuous cycle by learning how 
to improve their body function 
and understand chronic pain 
problems
Fig. 8  Principle of the interdis-
ciplinary pain center system. An 
interdisciplinary pain center is 
a single unit-based system for 
carrying out multidisciplinary 
pain management. The center 
has a broad range of clinical 
staff, patient care services, pain 
conditions treated, and educa-
tional and research activities
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addition, physical therapists work toward the functional 
improvement of the body. Clinical psychologists analyze 
the background of the patient and perform psychotherapeu-
tic interventions.
Numerous interdisciplinary pain centers that act as sin-
gle units with all these functions have been founded in vari-
ous countries [25]. As these centers have achieved excel-
lent treatment outcomes with various new attempts, such as 
group treatment, we have experimentally tried this approach 
at our own institution and have achieved definite improve-
ments with this design, even in refractory cases [26].
Conclusion
Musculoskeletal pain commonly becomes chronic. How-
ever, it is often the case that not only functional, but also 
numerous components such as psychosocial issues cause 
the pain to become prolonged. When providing treatment, 
detailed examination of the clinical condition at the site of 
the pain is certainly essential, but analysis of the condition 
should also include observation of the patient from various 
perspectives, including their environment. As all sorts of 
new treatments continue to be developed with the progress 
of medical care, each new treatment modality will inevi-
tably show some form of disadvantage, and the problems 
mentioned above must be considered to ensure the provi-
sion of treatment that not only aims at controlling pain, but 
also considers the widespread improvement of the ADL 
and QOL as a matter of primary importance.
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